Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study
- 1 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 22 (3), 352-360
- https://doi.org/10.1093/europace/euz339
Abstract
Aims Atrial fibrillation (AF) is a progressive disease, but identifying patients at risk for AF progression is challenging. We aimed to identify factors associated with AF progression. Methods and results Atrial fibrillation progression was assessed in 392 patients with recent-onset paroxysmal or persistent AF included in the prospective, observational, multicentre identification of a risk profile to guide atrial fibrillation (AF-RISK) study. Progression of AF was assessed by Hotter monitoring and 2-week event recorder at baseline and 1-year follow-up. AF progression was defined as: (i) doubling in AF burden at 1 year compared to baseline with a minimum AF burden of 10% in paroxysmal AF; or (ii) transition from paroxysmal to persistent or permanent AF; or (iii) persistent to permanent AF. Age was 60 +/- 11 years, 62% were men, and 83% had paroxysmal AF. At 1 year, 52 (13%) had AF progression (11% in paroxysmal; 26% in persistent AF). Multivariable logistic regression showed that left atrial volume [odds ratio (OR) per 10 mL 1.251, 95% confidence interval (CI) 1.078-1.450; P < 0.001], N-terminal pro-B-type natriuretic peptide (NT-proBNP; OR per standard deviation increase 1.583, 95% CI 1.099-2.281; P = 0.014), and plasminogen activator inhibitor-1 (PAI-1; OR per standard deviation increase 0.660, 95% CI 0.472 0.921; P = 0.015) were associated with AF progression. In an additional follow-up of 1.9 (0.9 3.3) years patients with AF progression developed more cardiovascular events and all-cause mortality (12.4%/year vs. 2.3%/year, P < 0.001). Conclusion Atrial fibrillation progression occurred in 13% of patients with recent-onset AF during 1-year follow-up. Left atrial volume, NT-proBNP, and PAI-1 were associated with AF progression. Patients with AF progression had a higher event rate.Keywords
Funding Information
- Dutch Heart Foundation (NHS2010B233)
This publication has 20 references indexed in Scilit:
- Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysisHeart Rhythm, 2018
- Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart FailureJournal of the American College of Cardiology, 2018
- Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart AssociationCirculation, 2018
- Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillationEP Europace, 2018
- Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trialEuropean Heart Journal, 2018
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implicationEP Europace, 2016
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEP Europace, 2016
- Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROESEuropean Heart Journal, 2014
- Progression From Paroxysmal to Persistent Atrial FibrillationJournal of the American College of Cardiology, 2010
- Recommendations for chamber quantification☆European Heart Journal - Cardiovascular Imaging, 2006